Goldman Sachs BDC Inc is a credit services business based in the US. Goldman Sachs BDC shares (GSBD) are listed on the NYSE and all prices are listed in US Dollars.
Our top pick for
Guided investing
Our top pick for
Building a portfolio
Our top pick for
Beginners
| Latest market close | $19.71 |
|---|---|
| 52-week range | $15.37 - $19.94 |
| 50-day moving average | $19.13 |
| 200-day moving average | $19.29 |
| Wall St. target price | $19.25 |
| PE ratio | 6.0521 |
| Dividend yield | $1.8 (9.11%) |
| Earnings per share (TTM) | $3.27 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $19.71 from 2022-01-20
| 1 week (2022-01-14) | -0.25% |
|---|---|
| 1 month (2021-12-21) | 2.98% |
| 3 months (2021-10-21) | 3.03% |
| 6 months (2021-07-21) | 2.92% |
| 1 year (2021-01-21) | 7.29% |
|---|---|
| 2 years (2020-01-21) | -7.07% |
| 3 years (2019-01-18) | 20.03 |
| 5 years (2017-01-20) | 22.79 |
Valuing Goldman Sachs BDC stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Goldman Sachs BDC's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Goldman Sachs BDC's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 6x. In other words, Goldman Sachs BDC shares trade at around 6x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Goldman Sachs BDC's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.15. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Goldman Sachs BDC's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
| Revenue TTM | $342.2 million |
|---|---|
| Operating margin TTM | 85.8% |
| Gross profit TTM | $173 million |
| Return on assets TTM | 7.5% |
| Return on equity TTM | 29.03% |
| Profit margin | 95.31% |
| Book value | $15.92 |
| Market capitalisation | $2 billion |
TTM: trailing 12 months
Dividend payout ratio: 56.86% of net profits
Recently Goldman Sachs BDC has paid out, on average, around 56.86% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 9.11% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Goldman Sachs BDC shareholders could enjoy a 9.11% return on their shares, in the form of dividend payments. In Goldman Sachs BDC's case, that would currently equate to about $1.8 per share.
Goldman Sachs BDC's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Goldman Sachs BDC's most recent dividend payout was on 26 January 2022. The latest dividend was paid out to all shareholders who bought their shares by 29 December 2021 (the "ex-dividend date").
Over the last 12 months, Goldman Sachs BDC's shares have ranged in value from as little as $15.3716 up to $19.94. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Goldman Sachs BDC's is 1.4714. This would suggest that Goldman Sachs BDC's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Goldman Sachs BDC, Inc. is a business development company specializing in middle market and mezzanine investment in private companies. It seeks to make capital appreciation through direct originations of secured debt, senior secured debt, junior secured debt, including first lien, first lien/last-out unitranche and second lien debt, unsecured debt, including mezzanine debt and, to a lesser extent, investments in equities. The fund primarily invests in United States. It seeks to invest between $10 million and $75 million in companies with EBITDA between $5 million and $75 million annually. .
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.